Penumbra Inc (PEN) stock
PENNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 15/3074% above fair value
$320.62−0.29 (-0.09%)
Close on Nov 16, 2026Market cap $12.64BP/E 80.8Yield –
Penumbra cash
Cash and short-term investments held at the end of each period.
Penumbra's cash was $673.61M at Sep 30, 2026. For fiscal 2025 it was $544.82M, up 60.2% from the year before. Over ten years it grew 39.5% a year on average. The highest annual figure on record is $544.82M in fiscal 2025.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $544.82M | +60.2% |
| FY2024 | Dec 31, 2024 | $340.13M | +17.6% |
| FY2023 | Dec 31, 2023 | $289.19M | +53.8% |
| FY2022 | Dec 31, 2022 | $188.03M | -26.2% |
| FY2021 | Dec 31, 2021 | $254.88M | -3.8% |
| FY2020 | Dec 31, 2020 | $264.83M | +263.9% |
| FY2019 | Dec 31, 2019 | $72.78M | +7.3% |
| FY2018 | Dec 31, 2018 | $67.85M | +34.0% |
| FY2017 | Dec 31, 2017 | $50.64M | +282.6% |
| FY2016 | Dec 31, 2016 | $13.24M | -32.3% |
| FY2015 | Dec 31, 2015 | $19.55M | +494.1% |
| FY2014 | Dec 31, 2014 | $3.29M | -20.4% |
| FY2013 | Dec 31, 2013 | $4.13M | -44.4% |
| FY2012 | Dec 31, 2012 | $7.44M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $673.61M | +43.2% |
| Q2 FY2026 | Jun 30, 2026 | $658.80M | +55.2% |
| Q1 FY2026 | Mar 31, 2026 | $615.66M | +62.5% |
| Q4 FY2025 | Dec 31, 2025 | $544.82M | +60.2% |
| Q3 FY2025 | Sep 30, 2025 | $470.30M | +61.6% |
| Q2 FY2025 | Jun 30, 2025 | $424.56M | +25.0% |
| Q1 FY2025 | Mar 31, 2025 | $378.85M | +20.9% |
| Q4 FY2024 | Dec 31, 2024 | $340.13M | +17.6% |
| Q3 FY2024 | Sep 30, 2024 | $291.02M | +16.9% |
| Q2 FY2024 | Jun 30, 2024 | $339.70M | +53.7% |
| Q1 FY2024 | Mar 31, 2024 | $313.47M | +57.4% |
| Q4 FY2023 | Dec 31, 2023 | $289.19M | +53.8% |
| Q3 FY2023 | Sep 30, 2023 | $248.86M | +34.9% |
| Q2 FY2023 | Jun 30, 2023 | $221.06M | +8.2% |
| Q1 FY2023 | Mar 31, 2023 | $199.10M | -17.2% |
| Q4 FY2022 | Dec 31, 2022 | $188.03M | -26.2% |
| Q3 FY2022 | Sep 30, 2022 | $184.43M | -30.9% |
| Q2 FY2022 | Jun 30, 2022 | $204.37M | +148.4% |
| Q1 FY2022 | Mar 31, 2022 | $240.34M | +332.0% |
| Q4 FY2021 | Dec 31, 2021 | $254.88M | -3.8% |
| Q3 FY2021 | Sep 30, 2021 | $266.93M | +233.2% |
| Q2 FY2021 | Jun 30, 2021 | $82.28M | -38.8% |
| Q1 FY2021 | Mar 31, 2021 | $55.63M | -23.2% |
| Q4 FY2020 | Dec 31, 2020 | $264.83M | +263.9% |
| Q3 FY2020 | Sep 30, 2020 | $80.12M | -28.2% |
| Q2 FY2020 | Jun 30, 2020 | $134.38M | +73.9% |
| Q1 FY2020 | Mar 31, 2020 | $72.46M | -24.2% |
| Q4 FY2019 | Dec 31, 2019 | $72.78M | +7.3% |
| Q3 FY2019 | Sep 30, 2019 | $111.58M | +133.7% |
| Q2 FY2019 | Jun 30, 2019 | $77.26M | +29.4% |
| Q1 FY2019 | Mar 31, 2019 | $95.61M | +88.8% |
| Q4 FY2018 | Dec 31, 2018 | $67.85M | +34.0% |
| Q3 FY2018 | Sep 30, 2018 | $47.74M | -27.2% |
| Q2 FY2018 | Jun 30, 2018 | $59.71M | -22.0% |
| Q1 FY2018 | Mar 31, 2018 | $50.64M | -53.7% |
| Q4 FY2017 | Dec 31, 2017 | $50.64M | +282.6% |
| Q3 FY2017 | Sep 30, 2017 | $65.62M | – |
| Q2 FY2017 | Jun 30, 2017 | $76.58M | – |
| Q1 FY2017 | Mar 31, 2017 | $109.38M | – |
| Q4 FY2016 | Dec 31, 2016 | $13.24M | – |
See a number that looks wrong?